Lv2
120 积分 2023-05-27 加入
Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment
1天前
已完结
The Role of Ki-67 and Pre-cytoreduction Parameters in Selecting Diffuse Malignant Peritoneal Mesothelioma (DMPM) Patients for Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
2个月前
已完结
Systemic Therapy and Surgical Management of Peritoneal Mesothelioma
3个月前
已关闭
Diagnosis and Management of Nonislet Cell Tumor Hypoglycemia
3个月前
已完结
The Combination of Handgrip Strength and CONUT Predicts Overall Survival in Patients with Gastrointestinal Cancer: A Multicenter Cohort Study
4个月前
已完结
Response to Ipilimumab and Nivolumab in a Patient With Malignant Peritoneal Mesothelioma
5个月前
已完结
Clinical outcome and prognostic factors for immunotherapy-based treatments in patients with platinum-refractory germ cell tumor
8个月前
已完结
Cytoreductive Surgery Plus HIPEC With and Without NIPEC for Malignant Peritoneal Mesothelioma: A Propensity-Matched Analysis
10个月前
已完结
Conditional Survival Following Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Surface Malignancies: An Analysis from the US HIPEC Collaborative
10个月前
已完结
[Primary peritoneal epithelioid mesothelioma with a STK11 gene mutation: report of a case]
1年前
已完结
皖公网安备34019202002308
